V. Ćorić

BPC 157's effect on healing

P. Sikiric, S. Seiwerth, R. Ručman, 1997, Journal of Physiology-Paris.

An open-label phase II study of first- and second-line treatment with brivanib in patients with hepatocellular carcinoma (HCC).

R. Finn, Yoon-Koo Kang, Joong-Won Park, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and mice

G. Aralica, I. Prkačin, T. Anić, 1999, Journal of Physiology-Paris.